66 related articles for article (PubMed ID: 37756307)
1. Myeloid‑derived suppressor cell accumulation induces Treg expansion and modulates lung malignancy progression.
Wan Y; Mu X; Zhao J; Li L; Xu W; Zhang M
Biomed Rep; 2024 Apr; 20(4):68. PubMed ID: 38533389
[TBL] [Abstract][Full Text] [Related]
2. Tumor-induced peripheral immunosuppression promotes brain metastasis in patients with non-small cell lung cancer.
Li YD; Lamano JB; Lamano JB; Quaggin-Smith J; Veliceasa D; Kaur G; Biyashev D; Unruh D; Bloch O
Cancer Immunol Immunother; 2019 Sep; 68(9):1501-1513. PubMed ID: 31489465
[TBL] [Abstract][Full Text] [Related]
3. The diversity of peripheral blood T cells and myeloid-derived suppressor cells in patients with idiopathic membranous nephropathy.
Shi X; Zhang M; Wang G; Chen G; Hu R; Lee X; Li X
Clin Nephrol; 2024 Jun; 101(6):287-297. PubMed ID: 38511675
[TBL] [Abstract][Full Text] [Related]
4. Global stability and parameter analysis reinforce therapeutic targets of PD-L1-PD-1 and MDSCs for glioblastoma.
Anderson HG; Takacs GP; Harris DC; Kuang Y; Harrison JK; Stepien TL
J Math Biol; 2023 Dec; 88(1):10. PubMed ID: 38099947
[TBL] [Abstract][Full Text] [Related]
5. Obesity correlates with the immunosuppressive ILC2s-MDSCs axis in advanced breast cancer.
Liu W; Li B; Liu D; Zhao B; Sun G; Ding J
Immun Inflamm Dis; 2024 Mar; 12(3):e1196. PubMed ID: 38501542
[TBL] [Abstract][Full Text] [Related]
6. Pivotal role of myeloid-derived suppressor cells in infection-related tumor growth.
Ito N; Tsujimoto H; Miyazaki H; Takahata R; Ueno H
Cancer Med; 2024 Feb; 13(4):e6917. PubMed ID: 38457241
[TBL] [Abstract][Full Text] [Related]
7. Monocytic myeloid-derived suppressor cells as an immune indicator of early diagnosis and prognosis in patients with sepsis.
Cui J; Cai W; Lin J; Zhang L; Miao Y; Xu Y; Zhao W
BMC Infect Dis; 2024 Apr; 24(1):399. PubMed ID: 38609858
[TBL] [Abstract][Full Text] [Related]
8. [Research advances of myeloid-derived suppressor cells mediated by programmed death-1/programmed death-ligand 1 pathway in sepsis-induced immunosuppression].
Xu Y; Zang X; Chen W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Mar; 36(3):332-336. PubMed ID: 38538366
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic Analysis of Circulating Myeloid Derived Suppressor Cells and Their Subpopulations in Egyptian Females with Breast Cancer: A Single-Centre Case-Control Study.
Saed SM; Abbas S; El Ansary MS; Abdelfattah W; Maurice KK; Mohamed ME; Tawfik Koptan DM
Asian Pac J Cancer Prev; 2024 Jan; 25(1):257-263. PubMed ID: 38285792
[TBL] [Abstract][Full Text] [Related]
10. IL-6 is associated with expansion of myeloid-derived suppressor cells and enhanced immunosuppression in pancreatic adenocarcinoma patients.
Sharma V; Sachdeva N; Gupta V; Nada R; Jacob J; Sahni D; Aggarwal A
Scand J Immunol; 2021 Dec; 94(6):e13107. PubMed ID: 38192074
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites.
Hou Y; Yang K; Wang L; Wang J; Huang X; Piffkó A; Luo SZ; Yu X; Rao E; Martinez C; Bugno J; Mack M; Vokes EE; Pitroda SP; Chmura SJ; Weichselbaum RR; Liang HL
Clin Cancer Res; 2024 May; 30(9):1945-1958. PubMed ID: 38427437
[TBL] [Abstract][Full Text] [Related]
12. Role of myeloid-derived suppressor cells in chronic brucellosis.
Hou S; Kong F; Li X; Xu Y; Chen S; Zhang S; Zhang L; Li T; Fu Y; Li C; Wang W
Front Cell Infect Microbiol; 2024; 14():1347883. PubMed ID: 38352057
[TBL] [Abstract][Full Text] [Related]
13. High-dimensional phenotyping of the peripheral immune response in community-acquired pneumonia.
Reijnders TDY; Schuurman AR; Verhoeff J; van den Braber M; Douma RA; Faber DR; Paul AGA; Wiersinga WJ; Saris A; Garcia Vallejo JJ; van der Poll T
Front Immunol; 2023; 14():1260283. PubMed ID: 38077404
[TBL] [Abstract][Full Text] [Related]
14. Circulating myeloid-derived suppressor cells may be a useful biomarker in the follow-up of unvaccinated COVID-19 patients after hospitalization.
Jiménez-Cortegana C; Salamanca E; Palazón-Carrión N; Sánchez-Jiménez F; Pérez-Pérez A; Vilariño-García T; Fuentes S; Martín S; Jiménez M; Galván R; Rodríguez-Chacón C; Sánchez-Mora C; Moreno-Mellado E; Gutiérrez-Gutiérrez B; Álvarez N; Sosa A; Garnacho-Montero J; de la Cruz-Merino L; Rodríguez-Baño J; Sánchez-Margalet V
Front Immunol; 2023; 14():1266659. PubMed ID: 38035104
[TBL] [Abstract][Full Text] [Related]
15. The distribution of myeloid-derived suppressor cells subsets and up-regulation of programmed death-1/PD-L1 axis in peripheral blood of adult CAP patients.
Gong H; Zhao J; Xu W; Wan Y; Mu X; Zhang M
PLoS One; 2023; 18(9):e0291455. PubMed ID: 37756307
[TBL] [Abstract][Full Text] [Related]
16. The clinical association of programmed death-1/PD-L1 axis, myeloid derived suppressor cells subsets and regulatory T cells in peripheral blood of stable COPD patients.
Zhang M; Wan Y; Han J; Li J; Gong H; Mu X
PeerJ; 2024; 12():e16988. PubMed ID: 38560459
[TBL] [Abstract][Full Text] [Related]
17. Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils.
Li C; Chen C; Kang X; Zhang X; Sun S; Guo F; Wang Q; Kou X; Bai W; Zhao A
Hum Reprod; 2020 Dec; 35(12):2677-2691. PubMed ID: 33067638
[TBL] [Abstract][Full Text] [Related]
18. Programmed Death-Ligand 1 Expression Potentiates the Immune Modulatory Function Of Myeloid-Derived Suppressor Cells in Systemic Lupus Erythematosus.
Park MJ; Baek JA; Choi JW; Jang SG; Kim DS; Park SH; Cho ML; Kwok SK
Front Immunol; 2021; 12():606024. PubMed ID: 33986739
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
